A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trialDaisuke Tomizawa, Katsuyoshi Koh, Takako Miyamura et al.|Blood|2020Cited by 102
Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemiaTomoya Isobe, Berthold Göttgens, Hiroo Ueno et al.|Nature Communications|2022Cited by 36
Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndromeTakashi Taga, Daisuke Tomizawa, Shiro Tanaka et al.|Leukemia|2021Cited by 19
Prognostic and therapeutic factors influencing the clinical outcome of metastatic Ewing sarcoma family of tumors: A retrospective report from the Japan Ewing Sarcoma Study GroupKatsutsugu Umeda, Takako Miyamura, Kenji Yamada et al.|Pediatric Blood & Cancer|2020Cited by 9
Correction to: Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndromeTakashi Taga, Daisuke Tomizawa, Shiro Tanaka et al.|Leukemia|2021Cited by 4